ZyVersa Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2022 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
ZyVersa Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2022 to Q2 2024.
  • ZyVersa Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 835K shares, a 96.5% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 835K -22.8M -96.5% Jun 30, 2024 10-Q 2024-08-09
Q1 2024 835K -8.38M -90.9% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 402K +145K +56.1% Dec 31, 2023 10-Q 2024-08-09
Q3 2023 43.5M Sep 30, 2023 10-Q 2023-11-14
Q2 2023 23.7M Jun 30, 2023 10-Q 2023-08-21
Q1 2023 9.21M Mar 31, 2023 10-Q 2023-05-12
Q4 2022 258K Dec 31, 2022 10-K 2024-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.